Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Anatomic Stage IB Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Ductal Breast Carcinoma In Situ · Invasive Breast Carcinoma · Prognostic Stage I Breast Cancer AJCC v8 · Prognostic Stage IA Breast Cancer AJCC v8 · Prognostic Stage IB Breast Cancer AJCC v8 · Prognostic Stage II Breast Cancer AJCC v8 · Prognostic Stage IIA Breast Cancer AJCC v8 · Prognostic Stage IIB Breast Cancer AJCC v8 · Prognostic Stage III Breast Cancer AJCC v8 · Prognostic Stage IIIA Breast Cancer AJCC v8 · Prognostic Stage IIIB Breast Cancer AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Sporadic Breast Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • M D Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Abenaa M. Brewster) · 713-745-4949
    Contact: Principal Investigator (Abenaa M. Brewster)
Study leads
  • Abenaa M Brewster

    Principal Investigator

    M.D. Anderson Cancer Center